NEUROBIOL AGING:肥胖与脑血流量减少有关,但运动可以改善!

2021-05-06 MedSci原创 MedSci原创

肥胖(一般定义为身体质量指数BMI>30)已经被认为是一种慢性疾病。根据世界卫生组织(WHO)报告显示,肥胖已成为一种日益恶化的全球健康危机,超过10亿成年人超重,至少3亿诊断为肥胖。

肥胖(一般定义为身体质量指数BMI30)已经被认为是一种慢性疾病。根据世界卫生组织(WHO)报告显示,肥胖已成为一种日益恶化的全球健康危机,超过10亿成年人超重,至少3亿诊断为肥胖。超重或肥胖仍然是导致慢性病和残疾发生率的主要因素,同时给免疫系统带来了极大的压力。因此,寻找易于实施且具有成本效益的方法来解决肥胖问题,对健康尤为重要。

近日,发表在Neurobiology of Aging杂志的一项研究显示,超重或肥胖会大大减少大脑中的血液流动,但增加体育锻炼可以积极地改变甚至抵消这种脑血流量的减少。

在这项研究中,研究人员对来自爱尔兰纵向老龄化研究的495名年龄在50岁以上的参与者进行调查,通过不同的肥胖测量指标,包括体重指数,腰臀比,腰围和体育锻炼,探索其与脑血流量之间的关系。

结果显示,通过MRI扫描和分析技术对测脑血流量测量发现,体重指数,腰臀比和腰围增加与脑血流量降低有关,且腰围尺寸增加1cm与每增加1岁时大脑血流量的减少相同。然而,坚持体育锻炼或可改变肥胖与脑血流量减少之间的关联。

在应对脑血流减少时,该研究建议,每天至少进行1.52个小时中等轻度的体育锻炼,包括快走或骑自行车等。另外,研究人员强调,任何体育活动的增加,特别是已经融入日常生活中的活动,比如园艺,都有助于维持并可能改善脑血流量。

同时,研究人员表示,持续地健康地向大脑供血至关重要,因为可以确保大脑有足够的氧气和营养。如果大脑的血液流动受到损害,则会随着年龄的增长而导致严重的健康问题,例如增加痴呆症和阿尔茨海默氏病患病风险。众所周知,肥胖很容易让人患上与年龄有关的疾病,甚至在40岁以后,预期寿命降低多达6岁,女性的预期寿命降低多达7岁。

综上,该研究揭示了肥胖与血液供应减少之间的关联,但体育锻炼对超重或肥胖人群很重要,这有助于防止脑血流量减少以及由此引起的健康问题。

原始出处

Silvin P. Knight et al. Obesity is associated with reduced cerebral blood flow – modified by physical activity, Neurobiology of Aging (2021). DOI: 10.1016/j.neurobiolaging.2021.04.008

版权声明:
本网站所有内容来源注明为“williamhill asia 医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于williamhill asia 医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“williamhill asia 医学”。其它来源的文章系转载文章,或“williamhill asia 号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与williamhill asia 联系,williamhill asia 将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1767846, encodeId=f6541e6784645, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Fri Mar 18 01:04:06 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2075911, encodeId=6edf20e5911c7, content=<a href='/topic/show?id=b208891e986' target=_blank style='color:#2F92EE;'>#血流量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89179, encryptionId=b208891e986, topicName=血流量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a691420, createdName=30397604, createdTime=Sun May 30 16:04:06 CST 2021, time=2021-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2042275, encodeId=325f20422e5dc, content=<a href='/topic/show?id=754b8508329' target=_blank style='color:#2F92EE;'>#脑血流#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85083, encryptionId=754b8508329, topicName=脑血流)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b191324, createdName=marongnuan, createdTime=Fri Mar 11 08:04:06 CST 2022, time=2022-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1919255, encodeId=70a1191925516, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Mon Dec 27 00:04:06 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1767846, encodeId=f6541e6784645, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Fri Mar 18 01:04:06 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2075911, encodeId=6edf20e5911c7, content=<a href='/topic/show?id=b208891e986' target=_blank style='color:#2F92EE;'>#血流量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89179, encryptionId=b208891e986, topicName=血流量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a691420, createdName=30397604, createdTime=Sun May 30 16:04:06 CST 2021, time=2021-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2042275, encodeId=325f20422e5dc, content=<a href='/topic/show?id=754b8508329' target=_blank style='color:#2F92EE;'>#脑血流#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85083, encryptionId=754b8508329, topicName=脑血流)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b191324, createdName=marongnuan, createdTime=Fri Mar 11 08:04:06 CST 2022, time=2022-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1919255, encodeId=70a1191925516, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Mon Dec 27 00:04:06 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1767846, encodeId=f6541e6784645, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Fri Mar 18 01:04:06 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2075911, encodeId=6edf20e5911c7, content=<a href='/topic/show?id=b208891e986' target=_blank style='color:#2F92EE;'>#血流量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89179, encryptionId=b208891e986, topicName=血流量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a691420, createdName=30397604, createdTime=Sun May 30 16:04:06 CST 2021, time=2021-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2042275, encodeId=325f20422e5dc, content=<a href='/topic/show?id=754b8508329' target=_blank style='color:#2F92EE;'>#脑血流#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85083, encryptionId=754b8508329, topicName=脑血流)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b191324, createdName=marongnuan, createdTime=Fri Mar 11 08:04:06 CST 2022, time=2022-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1919255, encodeId=70a1191925516, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Mon Dec 27 00:04:06 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1767846, encodeId=f6541e6784645, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Fri Mar 18 01:04:06 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2075911, encodeId=6edf20e5911c7, content=<a href='/topic/show?id=b208891e986' target=_blank style='color:#2F92EE;'>#血流量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89179, encryptionId=b208891e986, topicName=血流量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a691420, createdName=30397604, createdTime=Sun May 30 16:04:06 CST 2021, time=2021-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2042275, encodeId=325f20422e5dc, content=<a href='/topic/show?id=754b8508329' target=_blank style='color:#2F92EE;'>#脑血流#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85083, encryptionId=754b8508329, topicName=脑血流)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b191324, createdName=marongnuan, createdTime=Fri Mar 11 08:04:06 CST 2022, time=2022-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1919255, encodeId=70a1191925516, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Mon Dec 27 00:04:06 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
    2021-12-27 sunylz

相关威廉亚洲官网

Am J Gastroenterology:体重增加对日本非肥胖人群非酒精性脂肪肝发病率的影响

非酒精性脂肪肝病(NAFLD)是最严重的脂肪性肝病之一,它的发病率不断上升,已经渐渐成为常见的慢性肝病。

BMC Medicine:合理营养,减少COVID-19疫情下营养不良和肥胖

大量证据表明,在食物短缺时期营养缺乏对健康有长期的影响。据估计,随着中低收入国家目前的大流行,COVID-19大流行将大幅增加各种形式的营养不良。特别令人关切但被低估的是,有可能增加营养不良和肥胖(营

Circulation:减肥手术可显著降低有心血管疾病的肥胖患者的主要不良心血管事件的发生率

减肥手术已被证实可显著降低心血管危险因素,但是,减肥手术是否也可以减少主要不良心血管事件?

Stroke:伴有或不伴阻塞性睡眠呼吸暂停的肥胖患者减肥手术后房颤和卒中风险

在接受腹腔镜可调胃束带减肥手术的肥胖患者中,尽管体重减轻程度相近,但OSA患者的AF和卒中发生率高于无OSA的患者。非AF和AF相关因素均与卒中风险增加有关。

Radiology:减肥不只为了美,还为了“出气”!

肥胖定义为可能损害健康的过度脂肪积累(体重指数[BMI] >30 kg/m2)。肥胖与高血压、卒中、糖尿病、以及某些癌症的发生相关,同时肥胖人群中过早死亡和罹患严重损害生活质量的慢性病的风险也较高。

BMC Med:肥胖的代谢特征与结直肠癌和子宫内膜癌相关,减肥后可逆转!

肥胖是至少13种不同类型癌症的一个重要危险因素。据估计,全球癌症负担总量的3.9%(2012年约为55万例)与肥胖有关,而5.7%(2012年约为80万例)归因于肥胖和2型糖尿病两者。实验和分子流行病